Approval · Notice of Compliance 15916 · 2014
ACTIKERALL: Notice of Compliance 15916
Issued July 31, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15916
- Date
- July 31, 2014
- Company
- Almirall Hermal Gmbh
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Topical antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTIKERALL | 02428946 | Marketed |
Medicinal ingredients
- FLUOROURACIL 0.5 PER
- SALICYLIC ACID 10 PER